198 related articles for article (PubMed ID: 19138239)
1. Increased risk of exacerbating gastrointestinal disease among elderly patients following treatment with calcium channel blockers.
Hamada A; Ishii J; Doi K; Hamada N; Miyazaki C; Hamada T; Ohwaki Y; Wada M; Nakashima K
J Clin Pharm Ther; 2008 Dec; 33(6):619-24. PubMed ID: 19138239
[TBL] [Abstract][Full Text] [Related]
2. Influence of calcium channel blockers in patients with gastrointestinal disease in Japanese community pharmacies.
Hamada A; Akiyoshi R; Ishii J; Hamada N; Miyazaki C; Hamada T; Ohwaki Y; Ikeda R; Wada M; Nakashima K
J Clin Pharm Ther; 2012 Feb; 37(1):74-7. PubMed ID: 21395634
[TBL] [Abstract][Full Text] [Related]
3. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada.
Rahme E; Barkun A; Nedjar H; Gaugris S; Watson D
Am J Gastroenterol; 2008 Apr; 103(4):872-82. PubMed ID: 18371130
[TBL] [Abstract][Full Text] [Related]
4. Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.
Kothari S; Nelson SP; Wu EQ; Beaulieu N; McHale JM; Dabbous OH
Curr Med Res Opin; 2009 Nov; 25(11):2703-9. PubMed ID: 19775195
[TBL] [Abstract][Full Text] [Related]
5. Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysis.
Bangalore S; Parkar S; Messerli FH
Am J Med; 2009 Apr; 122(4):356-65. PubMed ID: 19332231
[TBL] [Abstract][Full Text] [Related]
6. Prescribing proton pump inhibitors for initial treatment of acid-related gastrointestinal diseases in a managed care population.
Chan J; Hui RL; Szpakowski JL
Am J Manag Care; 2004 Jul; 10(7 Pt 1):433-41. PubMed ID: 15298365
[TBL] [Abstract][Full Text] [Related]
7. Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers.
Schneeweiss S; Soumerai SB; Maclure M; Dormuth C; Walker AM; Glynn RJ
Clin Pharmacol Ther; 2003 Oct; 74(4):388-400. PubMed ID: 14534526
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive drugs and new-onset diabetes: a retrospective longitudinal cohort study.
Jong GP; Chang MH; Tien L; Li SY; Liou YS; Lung CH; Ma T
Cardiovasc Ther; 2009; 27(3):159-63. PubMed ID: 19689614
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel blockade to prevent stroke in hypertension: a meta-analysis of 13 studies with 103,793 subjects.
Angeli F; Verdecchia P; Reboldi GP; Gattobigio R; Bentivoglio M; Staessen JA; Porcellati C
Am J Hypertens; 2004 Sep; 17(9):817-22. PubMed ID: 15363825
[TBL] [Abstract][Full Text] [Related]
10. Potential influence of antisecretory therapy on the development of Candida-associated intraabdominal infection.
Cat TB; Charash W; Hebert J; Marden BT; Corbett SM; Ahern J; Rebuck JA
Ann Pharmacother; 2008 Feb; 42(2):185-91. PubMed ID: 18212256
[TBL] [Abstract][Full Text] [Related]
11. Extent of use of immediate-release formulations of calcium channel blockers as antihypertensive monotherapy by primary care physicians: multicentric study from Bahrain.
Sequeira RP; Jassim Al Khaja KA; Mathur VS
J Postgrad Med; 2002; 48(3):172-5. PubMed ID: 12432188
[TBL] [Abstract][Full Text] [Related]
12. Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175,634 patients.
Costanzo P; Perrone-Filardi P; Petretta M; Marciano C; Vassallo E; Gargiulo P; Paolillo S; Petretta A; Chiariello M
J Hypertens; 2009 Jun; 27(6):1136-51. PubMed ID: 19451836
[TBL] [Abstract][Full Text] [Related]
13. Calcium channel blockers and myocardial infarction: a case--control study in a Japanese hospital.
Ohyama Y; Funao K; Kawabe E; Hayashi D; Yamazaki T; Iga T; Koide D; Ohe K; Kubota K
Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):487-92. PubMed ID: 12426933
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of national provider prescription of PPI gastroprotection among elderly NSAID users.
Abraham NS; Hartman C; Castillo D; Richardson P; Smalley W
Am J Gastroenterol; 2008 Feb; 103(2):323-32. PubMed ID: 18289200
[TBL] [Abstract][Full Text] [Related]
15. Difference between the frequencies of antisecretory drug prescriptions in users of buffered vs. enteric-coated low-dose aspirin therapies.
Hachiken H; Murai A; Wada K; Kuwahara T; Hosomi K; Takada M
Int J Clin Pharmacol Ther; 2013 Oct; 51(10):807-15. PubMed ID: 24040850
[TBL] [Abstract][Full Text] [Related]
16. Prognostic effects of calcium channel blockers on cardiac events, stroke and end-stage renal disease in patients with angina pectoris. Retrospective comparative study of benidipine, diltiazem and nifedipine.
Arioka I; Dohi S; Dohi S; Sakai K
Arzneimittelforschung; 2008; 58(9):435-40. PubMed ID: 18972872
[TBL] [Abstract][Full Text] [Related]
17. Use of calcium channel blockers for glaucoma.
Araie M; Mayama C
Prog Retin Eye Res; 2011 Jan; 30(1):54-71. PubMed ID: 20933604
[TBL] [Abstract][Full Text] [Related]
18. Criteria used by general practitioners in prescribing prokinetic or antisecretory drugs in patients with functional dyspepsia.
Monés J; Guilera M; Artés M; López JS; Guerrero T; Fillat O;
Rev Esp Enferm Dig; 2001 May; 93(5):281-92. PubMed ID: 11488106
[TBL] [Abstract][Full Text] [Related]
19. Sociodemographic factors influence use of proton pump inhibitors among users of nonsteroidal anti-inflammatory drugs.
van Boxel OS; Hagenaars MP; Smout AJ; Siersema PD
Clin Gastroenterol Hepatol; 2009 Aug; 7(8):855-61. PubMed ID: 19465157
[TBL] [Abstract][Full Text] [Related]
20. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
